Filkova L

No ORCID on file · 1 paper in corpus
2026
The EPMA journal ·doi:10.1007/s13167-026-00466-3

Routine tumor biomarkers remain among the most accessible tools in oncology. Yet, their clinical value is frequently weakened by a persistent specificity trap: abnormal results are often treated as cancer-specific signals, whereas normal re…